Kidney Diseases Completed Phase 3 Trials for Olmesartan (DB00275)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185159Olmesartan Medoxomil in Diabetes MellitusPrevention
NCT00362960Olmesartan Medoxomil and Diabetic NephropathyTreatment